Drugs / AbelaDrug200
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00810940 | Oct 2010 → Dec 2011 | brain injury | Abela Pharmaceuticals, Inc. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AbelaDrug200 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00810940 ↗ |
| Route | Intravenous | “then IV 100 ml same schedule for 24 hours” NCT00810940 ↗ |